191 related articles for article (PubMed ID: 30680892)
1. Aspirin for primary cardiovascular disease prevention: time to re-evaluate guidelines?
Barmanray R; Hamblin PS
Intern Med J; 2019 Jan; 49(1):133-134. PubMed ID: 30680892
[No Abstract] [Full Text] [Related]
2. Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?
Matthys F; De Backer T; De Backer G; Stichele RV
Eur J Prev Cardiol; 2014 Mar; 21(3):354-65. PubMed ID: 23610452
[TBL] [Abstract][Full Text] [Related]
3. Aspirin in primary prevention: USPSTF recommendations.
Aalbers J
Cardiovasc J Afr; 2010; 21(3):176. PubMed ID: 20532445
[No Abstract] [Full Text] [Related]
4. Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?
Noubiap JJ; Nansseu JR
Vasc Health Risk Manag; 2015; 11():503-6. PubMed ID: 26345154
[TBL] [Abstract][Full Text] [Related]
5. What have we learned about using aspirin for primary prevention from the ASCEND and ARRIVE trials?
Tousoulis D
Cardiovasc Res; 2019 Feb; 115(2):e15-e16. PubMed ID: 30668678
[No Abstract] [Full Text] [Related]
6. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.
Godley RW; Hernandez-Vila E
Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141
[No Abstract] [Full Text] [Related]
7. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
Rodondi N; Bauer DC
Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
[No Abstract] [Full Text] [Related]
8. AAA- a further step towards a moratorium for aspirin in the primary prevention.
Minar E
Vasa; 2010 May; 39(2):119-122. PubMed ID: 20521434
[No Abstract] [Full Text] [Related]
9. On the potential contribution of aspirin to healthy ageing programmes.
Morgan GP
Age Ageing; 2016 Mar; 45(2):e1-3. PubMed ID: 22101149
[No Abstract] [Full Text] [Related]
10. Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk.
Volpe M; Battistoni A; Gallo G; Coluccia R; De Caterina R
High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):331-339. PubMed ID: 28573479
[TBL] [Abstract][Full Text] [Related]
11. Impact of acetylsalicylic acid on primary prevention of cardiovascular diseases: A meta-analysis of randomized trials.
Upadhaya S; Madala S; Baniya R; Saginala K; Khan J
Eur J Prev Cardiol; 2019 May; 26(7):746-749. PubMed ID: 30861689
[TBL] [Abstract][Full Text] [Related]
12. What Do the Guidelines Really Say About Aspirin?
Millard MA; Hernandez-Vila EA
Tex Heart Inst J; 2018 Aug; 45(4):228-230. PubMed ID: 30374231
[No Abstract] [Full Text] [Related]
13. Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study.
Van't Hof JR; Duval S; Walts A; Kopecky SL; Luepker RV; Hirsch AT
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974502
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Efficacy in Primary Prevention: A Meta-analysis of Randomized Controlled Trials.
Barbarawi M; Kheiri B; Zayed Y; Gakhal I; Al-Abdouh A; Barbarawi O; Rashdan L; Rizk F; Bachuwa G; Alkotob ML
High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):283-291. PubMed ID: 31280451
[TBL] [Abstract][Full Text] [Related]
15. Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.
Al-Sofiani ME; Derenbecker R; Quartuccio M; Kalyani RR
Curr Diab Rep; 2019 Sep; 19(10):107. PubMed ID: 31544224
[TBL] [Abstract][Full Text] [Related]
16. Aspirin for Primary Prevention of Cardiovascular Disease.
Kheiri B; Barbarawi M; Bachuwa G; Shapiro MD
Circ Cardiovasc Qual Outcomes; 2019 Jun; 12(6):e005846. PubMed ID: 31163982
[No Abstract] [Full Text] [Related]
17. Aspirin for primary prevention of cardiovascular disease in women.
Jneid H
Methodist Debakey Cardiovasc J; 2010 Nov-2011 Jan; 6(4):37-42. PubMed ID: 21088658
[TBL] [Abstract][Full Text] [Related]
18. The Aspirin Primary Prevention Conundrum.
Schamroth Pravda M; Schamroth Pravda N; Beigel Y; Matetzky S; Beigel R
Isr Med Assoc J; 2020 Jan; 22(1):60-63. PubMed ID: 31927808
[TBL] [Abstract][Full Text] [Related]
19. Aspirin for primary prevention of cardiovascular disease in women: does sex matter?
Hung J
Med J Aust; 2006 Mar; 184(6):260-1. PubMed ID: 16548826
[TBL] [Abstract][Full Text] [Related]
20. Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials.
Soejima H; Morimoto T; Saito Y; Ogawa H
Thromb Haemost; 2010 Dec; 104(6):1085-8. PubMed ID: 20941462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
